+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Precision Medicine Market Research Report by Technology, Application, End User, Deployment, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 137 Pages
  • October 2022
  • Region: United States
  • 360iResearch™
  • ID: 5124372
UP TO OFF until Dec 31st 2022
The United States Precision Medicine Market size was estimated at USD 11.24 billion in 2021, USD 13.12 billion in 2022, and is projected to grow at a CAGR of 12.99% to reach USD 23.41 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Precision Medicine to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Technology, the market was studied across Big Data Analytics, Bioinformatics, Companion Diagnostics, Drug Discovery, and Gene Sequencing.
  • Based on Application, the market was studied across CNS, Immunology, Oncology, and Respiratory.
  • Based on End User, the market was studied across Biotechnology Diagnostic Companies, Laboratories & Pharmaceuticals, and Research Centers & Government Institutions.
  • Based on Deployment, the market was studied across On-Cloud and On-Premise.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies This research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Precision Medicine market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Precision Medicine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Precision Medicine Market, including Biocrates Life Sciences AG, Eagle Genomics Ltd, Intomics, Laboratory Corporation of America Holdings, Medtronic, Nanostring Technologies, Novartis AG, Pfizer Inc., Quest Diagnostics Incorporated, and Teva Pharmaceuticals.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Precision Medicine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Precision Medicine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Precision Medicine Market?
4. What is the competitive strategic window for opportunities in the United States Precision Medicine Market?
5. What are the technology trends and regulatory frameworks in the United States Precision Medicine Market?
6. What is the market share of the leading vendors in the United States Precision Medicine Market?
7. What modes and strategic moves are considered suitable for entering the United States Precision Medicine Market?
Frequently Asked Questions about the U.S. Precision Medicine Market

What is the estimated value of the U.S. Precision Medicine Market?

The U.S. Precision Medicine Market was estimated to be valued at $11.24 Billion in 2021.

What is the growth rate of the U.S. Precision Medicine Market?

The growth rate of the U.S. Precision Medicine Market is 12.9%, with an estimated value of $23.41 Billion by 2027.

What is the forecasted size of the U.S. Precision Medicine Market?

The U.S. Precision Medicine Market is estimated to be worth $23.41 Billion by 2027.

Who are the key companies in the U.S. Precision Medicine Market?

Key companies in the U.S. Precision Medicine Market include Biocrates Life Sciences AG, Eagle Genomics Ltd, Intomics, Laboratory Corporation of America Holdings, Medtronic, Nanostring Technologies, Novartis AG, Pfizer Inc. and Teva Pharmaceuticals.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Precision Medicine Market, by Technology
6.1. Introduction
6.2. Big Data Analytics
6.3. Bioinformatics
6.4. Companion Diagnostics
6.5. Drug Discovery
6.6. Gene Sequencing
7. Precision Medicine Market, by Application
7.1. Introduction
7.2. CNS
7.3. Immunology
7.4. Oncology
7.5. Respiratory
8. Precision Medicine Market, by End User
8.1. Introduction
8.2. Biotechnology Diagnostic Companies
8.3. Laboratories & Pharmaceuticals
8.4. Research Centers & Government Institutions
9. Precision Medicine Market, by Deployment
9.1. Introduction
9.2. On-Cloud
9.3. On-Premise
10. California Precision Medicine Market
10.1. Introduction
11. Florida Precision Medicine Market
11.1. Introduction
12. Illinois Precision Medicine Market
12.1. Introduction
13. New York Precision Medicine Market
13.1. Introduction
14. Ohio Precision Medicine Market
14.1. Introduction
15. Pennsylvania Precision Medicine Market
15.1. Introduction
16. Texas Precision Medicine Market
16.1. Introduction
17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis, By Key Player
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion
18. Company Usability Profiles
18.1. Biocrates Life Sciences AG
18.1.1. Business Overview
18.1.2. Key Executives
18.1.3. Product & Services
18.2. Eagle Genomics Ltd
18.2.1. Business Overview
18.2.2. Key Executives
18.2.3. Product & Services
18.3. Intomics
18.3.1. Business Overview
18.3.2. Key Executives
18.3.3. Product & Services
18.4. Laboratory Corporation of America Holdings
18.4.1. Business Overview
18.4.2. Key Executives
18.4.3. Product & Services
18.5. Medtronic
18.5.1. Business Overview
18.5.2. Key Executives
18.5.3. Product & Services
18.6. Nanostring Technologies
18.6.1. Business Overview
18.6.2. Key Executives
18.6.3. Product & Services
18.7. Novartis AG
18.7.1. Business Overview
18.7.2. Key Executives
18.7.3. Product & Services
18.8. Pfizer Inc.
18.8.1. Business Overview
18.8.2. Key Executives
18.8.3. Product & Services
18.9. Quest Diagnostics Incorporated
18.9.1. Business Overview
18.9.2. Key Executives
18.9.3. Product & Services
18.10. Teva Pharmaceuticals
18.10.1. Business Overview
18.10.2. Key Executives
18.10.3. Product & Services
19. Appendix
19.1. Discussion Guide
19.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES PRECISION MEDICINE MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES PRECISION MEDICINE MARKET SIZE, 2021 VS 2027
FIGURE 3. UNITED STATES PRECISION MEDICINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 4. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 6. UNITED STATES PRECISION MEDICINE MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 7. UNITED STATES PRECISION MEDICINE MARKET DYNAMICS
FIGURE 8. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD BILLION)
FIGURE 10. UNITED STATES PRECISION MEDICINE MARKET COMPETITIVE STRATEGIC WINDOW, BY TECHNOLOGY, 2027
FIGURE 11. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY BIG DATA ANALYTICS, 2018-2027 (USD BILLION)
FIGURE 12. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY BIOINFORMATICS, 2018-2027 (USD BILLION)
FIGURE 13. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2027 (USD BILLION)
FIGURE 14. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY DRUG DISCOVERY, 2018-2027 (USD BILLION)
FIGURE 15. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY GENE SEQUENCING, 2018-2027 (USD BILLION)
FIGURE 16. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 17. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD BILLION)
FIGURE 18. UNITED STATES PRECISION MEDICINE MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2027
FIGURE 19. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY CNS, 2018-2027 (USD BILLION)
FIGURE 20. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY IMMUNOLOGY, 2018-2027 (USD BILLION)
FIGURE 21. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2027 (USD BILLION)
FIGURE 22. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY RESPIRATORY, 2018-2027 (USD BILLION)
FIGURE 23. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 24. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY END USER, 2021 VS 2027 (USD BILLION)
FIGURE 25. UNITED STATES PRECISION MEDICINE MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2027
FIGURE 26. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY BIOTECHNOLOGY DIAGNOSTIC COMPANIES, 2018-2027 (USD BILLION)
FIGURE 27. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY LABORATORIES & PHARMACEUTICALS, 2018-2027 (USD BILLION)
FIGURE 28. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY RESEARCH CENTERS & GOVERNMENT INSTITUTIONS, 2018-2027 (USD BILLION)
FIGURE 29. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2021 VS 2027 (%)
FIGURE 30. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2021 VS 2027 (USD BILLION)
FIGURE 31. UNITED STATES PRECISION MEDICINE MARKET COMPETITIVE STRATEGIC WINDOW, BY DEPLOYMENT, 2027
FIGURE 32. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY ON-CLOUD, 2018-2027 (USD BILLION)
FIGURE 33. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY ON-PREMISE, 2018-2027 (USD BILLION)
FIGURE 34. CALIFORNIA PRECISION MEDICINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 35. FLORIDA PRECISION MEDICINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 36. ILLINOIS PRECISION MEDICINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 37. NEW YORK PRECISION MEDICINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 38. OHIO PRECISION MEDICINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 39. PENNSYLVANIA PRECISION MEDICINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 40. TEXAS PRECISION MEDICINE MARKET SIZE, 2018-2027 (USD BILLION)
FIGURE 41. UNITED STATES PRECISION MEDICINE MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 42. UNITED STATES PRECISION MEDICINE MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 43. UNITED STATES PRECISION MEDICINE MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. UNITED STATES PRECISION MEDICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. UNITED STATES PRECISION MEDICINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 4. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY STATE, 2018-2027 (USD BILLION)
TABLE 5. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 6. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY BIG DATA ANALYTICS, 2018-2027 (USD BILLION)
TABLE 7. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY BIG DATA ANALYTICS, BY STATE, 2018-2027 (USD BILLION)
TABLE 8. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY BIOINFORMATICS, 2018-2027 (USD BILLION)
TABLE 9. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY BIOINFORMATICS, BY STATE, 2018-2027 (USD BILLION)
TABLE 10. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2027 (USD BILLION)
TABLE 11. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY COMPANION DIAGNOSTICS, BY STATE, 2018-2027 (USD BILLION)
TABLE 12. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY DRUG DISCOVERY, 2018-2027 (USD BILLION)
TABLE 13. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY DRUG DISCOVERY, BY STATE, 2018-2027 (USD BILLION)
TABLE 14. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY GENE SEQUENCING, 2018-2027 (USD BILLION)
TABLE 15. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY GENE SEQUENCING, BY STATE, 2018-2027 (USD BILLION)
TABLE 16. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 17. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY CNS, 2018-2027 (USD BILLION)
TABLE 18. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY CNS, BY STATE, 2018-2027 (USD BILLION)
TABLE 19. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY IMMUNOLOGY, 2018-2027 (USD BILLION)
TABLE 20. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY IMMUNOLOGY, BY STATE, 2018-2027 (USD BILLION)
TABLE 21. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2027 (USD BILLION)
TABLE 22. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY ONCOLOGY, BY STATE, 2018-2027 (USD BILLION)
TABLE 23. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY RESPIRATORY, 2018-2027 (USD BILLION)
TABLE 24. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY RESPIRATORY, BY STATE, 2018-2027 (USD BILLION)
TABLE 25. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 26. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY BIOTECHNOLOGY DIAGNOSTIC COMPANIES, 2018-2027 (USD BILLION)
TABLE 27. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY BIOTECHNOLOGY DIAGNOSTIC COMPANIES, BY STATE, 2018-2027 (USD BILLION)
TABLE 28. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY LABORATORIES & PHARMACEUTICALS, 2018-2027 (USD BILLION)
TABLE 29. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY LABORATORIES & PHARMACEUTICALS, BY STATE, 2018-2027 (USD BILLION)
TABLE 30. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY RESEARCH CENTERS & GOVERNMENT INSTITUTIONS, 2018-2027 (USD BILLION)
TABLE 31. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY RESEARCH CENTERS & GOVERNMENT INSTITUTIONS, BY STATE, 2018-2027 (USD BILLION)
TABLE 32. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2027 (USD BILLION)
TABLE 33. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY ON-CLOUD, 2018-2027 (USD BILLION)
TABLE 34. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY ON-CLOUD, BY STATE, 2018-2027 (USD BILLION)
TABLE 35. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY ON-PREMISE, 2018-2027 (USD BILLION)
TABLE 36. UNITED STATES PRECISION MEDICINE MARKET SIZE, BY ON-PREMISE, BY STATE, 2018-2027 (USD BILLION)
TABLE 37. CALIFORNIA PRECISION MEDICINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 38. CALIFORNIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 39. CALIFORNIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 40. CALIFORNIA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 41. CALIFORNIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2027 (USD BILLION)
TABLE 42. FLORIDA PRECISION MEDICINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 43. FLORIDA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 44. FLORIDA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 45. FLORIDA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 46. FLORIDA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2027 (USD BILLION)
TABLE 47. ILLINOIS PRECISION MEDICINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 48. ILLINOIS PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 49. ILLINOIS PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 50. ILLINOIS PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 51. ILLINOIS PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2027 (USD BILLION)
TABLE 52. NEW YORK PRECISION MEDICINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 53. NEW YORK PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 54. NEW YORK PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 55. NEW YORK PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 56. NEW YORK PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2027 (USD BILLION)
TABLE 57. OHIO PRECISION MEDICINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 58. OHIO PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 59. OHIO PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 60. OHIO PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 61. OHIO PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2027 (USD BILLION)
TABLE 62. PENNSYLVANIA PRECISION MEDICINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 63. PENNSYLVANIA PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 64. PENNSYLVANIA PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 65. PENNSYLVANIA PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 66. PENNSYLVANIA PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2027 (USD BILLION)
TABLE 67. TEXAS PRECISION MEDICINE MARKET SIZE, 2018-2027 (USD BILLION)
TABLE 68. TEXAS PRECISION MEDICINE MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD BILLION)
TABLE 69. TEXAS PRECISION MEDICINE MARKET SIZE, BY APPLICATION, 2018-2027 (USD BILLION)
TABLE 70. TEXAS PRECISION MEDICINE MARKET SIZE, BY END USER, 2018-2027 (USD BILLION)
TABLE 71. TEXAS PRECISION MEDICINE MARKET SIZE, BY DEPLOYMENT, 2018-2027 (USD BILLION)
TABLE 72. UNITED STATES PRECISION MEDICINE MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 73. UNITED STATES PRECISION MEDICINE MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 74. UNITED STATES PRECISION MEDICINE MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 75. UNITED STATES PRECISION MEDICINE MARKET RANKING, BY KEY PLAYER, 2021
TABLE 76. UNITED STATES PRECISION MEDICINE MARKET SHARE, BY KEY PLAYER, 2021
TABLE 77. UNITED STATES PRECISION MEDICINE MARKET MERGER & ACQUISITION
TABLE 78. UNITED STATES PRECISION MEDICINE MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 79. UNITED STATES PRECISION MEDICINE MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 80. UNITED STATES PRECISION MEDICINE MARKET INVESTMENT & FUNDING
TABLE 81. UNITED STATES PRECISION MEDICINE MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 82. UNITED STATES PRECISION MEDICINE MARKET: LICENSE & PRICING

Companies Mentioned

  • Biocrates Life Sciences AG
  • Eagle Genomics Ltd
  • Intomics
  • Laboratory Corporation of America Holdings
  • Medtronic
  • Nanostring Technologies
  • Novartis AG
  • Pfizer Inc.
  • Quest Diagnostics Incorporated
  • Teva Pharmaceuticals

Methodology

Loading
LOADING...